Cerebroprotective effects of ibuprofen on diabetic encephalopathy in rats

Pharmacology Biochemistry and Behavior

Volumn 117, Issue , 2014, Pages 128-136

  Liu, Yao Wu ^a,b   Zhu, Xia ^a   Zhang, Liang ^a   Lu, Qian ^a   Zhang, Fan ^a   Guo, Hao ^a   Yin, Xiao Xing ^a,b  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

Advanced glycation endproducts; Diabetic encephalopathy; Ibuprofen; Inflammation; Peroxisome proliferator activated receptor ; amyloid precursor protein cleaving enzyme 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BETA SECRETASE 1; CYCLOOXYGENASE 2; IBUPROFEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APTITUDE; ARTICLE; BODY WEIGHT; COGNITION; CONTROLLED STUDY; DIABETIC ENCEPHALOPATHY; DIABETIC NEUROPATHY; DRUG MECHANISM; HIPPOCAMPUS; HYPERGLYCEMIA; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TEMPORAL CORTEX;

ADVANCED GLYCATION ENDPRODUCTS; DIABETIC ENCEPHALOPATHY; IBUPROFEN; INFLAMMATION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Γ; Β-AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BASE SEQUENCE; BODY WEIGHT; BRAIN DISEASES; DIABETES COMPLICATIONS; DNA PRIMERS; IBUPROFEN; LEARNING; MALE; MEMORY; NEUROPROTECTIVE AGENTS; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84891805373     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.11.027     Document Type: Article

References (40)

1. A. Bierhaus, and P.P. Nawroth Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications Diabetologia 52 2009 2251 2263
2. I. Blasko, F. Marx, E. Steiner, T. Hartmann, and B. Grubeck-Loebenstein TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs FASEB J 13 1999 63 68
3. H. Cai, Y. Wang, D. McCarthy, H. Wen, D.R. Borchelt, and D.L. Price et al. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons Nat Neurosci 4 2001 233 234
4. Z. Cai, Y. Zhao, S. Yao, and Zhao B. Bin Increases in beta-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-kappaB pathway activation Pharmacol Rep 63 2011 381 391
5. H.J. Cho, S.M. Son, S.M. Jin, H.S. Hong, D.H. Shin, and S.J. Kim et al. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model FASEB J 23 2009 2639 2649
6. N. Dauletbaev, J. Lam, D. Eklove, M. Iskandar, and L.C. Lands Ibuprofen modulates NF-kB activity but not IL-8 production in cystic fibrosis respiratory epithelial cells Respiration 79 2010 234 242
7. R. Deane, S. Du Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, and E. Hogg et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nat Med 9 2003 907 913
8. R. Del Bo, N. Angeretti, E. Lucca, M.G. De Simoni, and G. Forloni Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures Neurosci Lett 188 1995 70 74
9. M. Guglielmotto, M. Aragno, E. Tamagno, I. Vercellinatto, S. Visentin, and C. Medana et al. AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation Neurobiol Aging 33 2012 196.e13-27
10. B.T. Hawkins, S.M. Ocheltree, K.M. Norwood, and R.D. Egleton Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats Neurosci Lett 411 2007 1 5
11. M.T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, A. Hanke, I. Dewachter, and C. Kuiperi et al. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice Brain 128 2005 1442 1453
12. M. Ingelsson, H. Fukumoto, K.L. Newell, J.H. Growdon, E.T. Hedley-Whyte, and M.P. Frosch et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain Neurology 62 2004 925 931
13. M.S. Jaradat, B. Wongsud, S. Phornchirasilp, S.M. Rangwala, G. Shams, and M. Sutton et al. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin Biochem Pharmacol 62 2001 1587 1595
14. L.Y. Jiang, S.S. Tang, X.Y. Wang, L.P. Liu, Y. Long, and M. Hu et al. PPARgamma agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus CNS Neurosci Ther 18 2012 659 666
15. C.G. Jolivalt, R. Hurford, C.A. Lee, W. Dumaop, E. Rockenstein, and E. Masliah Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice Exp Neurol 223 2010 422 431
16. C.T. Kodl, and E.R. Seaquist Cognitive dysfunction and diabetes mellitus Endocr Rev 29 2008 494 511
17. L.A. Kotilinek, M.A. Westerman, Q. Wang, K. Panizzon, G.P. Lim, and A. Simonyi et al. Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity Brain 131 2008 651 664
18. L.P. Liu, H. Hong, J.M. Liao, T.S. Wang, J. Wu, and S.S. Chen et al. Upregulation of RAGE at the blood-brain barrier in streptozotocin-induced diabetic mice Synapse 63 2009 636 642
19. Y.W. Liu, X. Zhu, W. Li, Q. Lu, J.Y. Wang, and Y.Q. Wei et al. Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats Pharmacol Biochem Behav 101 2012 93 98
20. Y.W. Liu, X. Zhu, Q. Lu, J.Y. Wang, W. Li, and Y.Q. Wei et al. Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain J Ethnopharmacol 139 2012 194 200
21. L.P. Liu, T.H. Yan, L.Y. Jiang, W. Hu, M. Hu, and C. Wang et al. Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain beta-amyloid through PPARgamma activation Acta Pharmacol Sin 34 2013 455 463
22. Y.W. Liu, X. Zhu, Q.Q. Yang, Q. Lu, J.Y. Wang, and H.P. Li et al. Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats Psychopharmacology (Berl) 228 4 2013 585 594
23. Y. Luo, B. Bolon, S. Kahn, B.D. Bennett, S. Babu-Khan, and P. Denis et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation Nat Neurosci 4 2001 231 232
24. A.C. McKee, I. Carreras, L. Hossain, H. Ryu, W.L. Klein, and S. Oddo et al. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice Brain Res 1207 2008 225 236
25. G.S. Mijnhout, P. Scheltens, M. Diamant, G.J. Biessels, A.M. Wessels, and S. Simsek et al. Diabetic encephalopathy: a concept in need of a definition Diabetologia 49 2006 1447 1448
26. R. Peila, B.L. Rodriguez, and L.J. Launer Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study Diabetes 51 2002 1256 1262
27. W.W. Qi, L.Y. Zhong, X.R. Li, G. Li, Z.X. Liu, and J.F. Hu et al. Hyperglycemia induces the variations of 11beta-hydroxysteroid dehydrogenase type 1 and peroxisome proliferator-activated receptor-gamma expression in hippocampus and hypothalamus of diabetic rats Exp Diabetes Res 2012 2012 107130
28. M. Sastre, I. Dewachter, G.E. Landreth, T.M. Willson, T. Klockgether, and F. van Leuven et al. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase J Neurosci 23 2003 9796 9804
29. M. Sastre, I. Dewachter, S. Rossner, N. Bogdanovic, E. Rosen, and P. Borghgraef et al. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma Proc Natl Acad Sci U S A 103 2006 443 448
30. D.J. Selkoe Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein Ann N Y Acad Sci 924 2000 17 25
31. A.A. Sima Encephalopathies: the emerging diabetic complications Acta Diabetol 47 2010 279 293
32. Y. Takada, A. Bhardwaj, P. Potdar, and B.B. Aggarwal Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation Oncogene 23 2004 9247 9258
33. S. Takeda, N. Sato, K. Uchio-Yamada, K. Sawada, T. Kunieda, and D. Takeuchi et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes Proc Natl Acad Sci U S A 107 2010 7036 7041
34. D. Van Dam, K. Coen, and P.P. De Deyn Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model J Psychopharmacol 24 2010 383 388
35. A.W. van Deutekom, H.W. Niessen, C.G. Schalkwijk, R.J. Heine, and S. Simsek Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus Eur J Endocrinol 158 2008 655 660
36. S.H. Wang, Z.L. Sun, Y.J. Guo, Y. Yuan, and B.Q. Yang Diabetes impairs hippocampal function via advanced glycation end product mediated new neuron generation in animals with diabetes-related depression Toxicol Sci 111 2009 72 79
37. X. Wang, W. Zheng, J.W. Xie, T. Wang, S.L. Wang, and W.P. Teng et al. Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model Mol Neurodegener 5 2010 46
38. C.Y. Wang, J.W. Xie, Y. Xu, T. Wang, X. Wang, and J.H. Cai et al. Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-kappa B pathway in a transgenic mouse model of Alzheimer's disease Antioxid Redox Signal 19 17 2013 2024 2039
39. M. Yamamoto, T. Kiyota, M. Horiba, J.L. Buescher, S.M. Walsh, and H.E. Gendelman et al. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice Am J Pathol 170 2007 680 692
40. S. Yoneda, H. Hara, A. Hirata, M. Fukushima, Y. Inomata, and H. Tanihara Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases Jpn J Ophthalmol 49 2005 106 108